National HealthCare Corporation

NHC Healthcare Medical Care Facilities

National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024.

Revenue
+6.61%
EPS
−65.6%
Free cash flow
+75.5%
Total debt
+216.7%

Quarter to September 2026, against a year earlier

207.47 4.93 −2.32%
Market cap
$3.3B
P/E
28.2×
Fwd P/E
8.4×
Dividend yield
1.26%
F-score
7/9
Altman Z
5.02
Beneish M
−2.57
Dividend safety
74/100

National HealthCare Corporation (NHC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, National HealthCare Corporation (NHC) trades at a EV/Sales of 1.9×. Over the past ten years it has ranged from 0.6× (March 2023) to 2.3× (October 2026); the current reading is higher than 97% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.2× 6.66%
FY2024 1.2× 6.54%
FY2023 1.1× 65.24%
FY2022 0.7× (7.29%)
FY2021 0.7× 4.41%
FY2020 0.7× (38.80%)
FY2019 1.1× 8.92%
FY2018 1.0× 33.20%
FY2017 0.8× (27.57%)
FY2016 1.1× 35.93%

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.1× 3.09%
Jun 2026 2.0× 35.60%
Mar 2026 1.5× 18.39%
Dec 2025 1.2× 15.96%
43 more quarters

Against its own ten years

Low 0.6× High 2.3×
Ten-year median 0.9×
Current reading's percentile 97

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on NHC